70 related articles for article (PubMed ID: 3862606)
41. Investigation of basal metabolic rates and whole body measures of oxidant damage in vivo.
Moore GW; Strain JJ; Nevin GB; Livingstone MB; Hannigan BM; McKenna PG
Biochem Soc Trans; 1990 Apr; 18(2):355-6. PubMed ID: 2379757
[No Abstract] [Full Text] [Related]
42. Lung oxidant toxicity.
Cross CE
Calif Med; 1973 Nov; 119(5):48. PubMed ID: 18731038
[No Abstract] [Full Text] [Related]
43. N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks).
Schwalfenberg GK
J Nutr Metab; 2021; 2021():9949453. PubMed ID: 34221501
[TBL] [Abstract][Full Text] [Related]
44. N-acetylcysteine in COPD: why, how, and when?
Sanguinetti CM
Multidiscip Respir Med; 2015; 11():8. PubMed ID: 26855777
[TBL] [Abstract][Full Text] [Related]
45. Comparative study on the selenium- and N-acetylcysteine-related effects on the toxic action of hyperoxia, paraquat and the enzyme reaction hypoxanthine-xanthine oxidase in cultured endothelial cells.
Junod AF; Jornot L; Grichting G
Agents Actions; 1987 Oct; 22(1-2):176-83. PubMed ID: 3687596
[TBL] [Abstract][Full Text] [Related]
46. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine.
Roederer M; Staal FJ; Raju PA; Ela SW; Herzenberg LA; Herzenberg LA
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4884-8. PubMed ID: 2112750
[TBL] [Abstract][Full Text] [Related]
47. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine.
Bridgeman MM; Marsden M; MacNee W; Flenley DC; Ryle AP
Thorax; 1991 Jan; 46(1):39-42. PubMed ID: 1871695
[TBL] [Abstract][Full Text] [Related]
48. [Therapeutic use of N-acetylcysteine in acute lung diseases].
Domenighetti G; Quattropani C; Schaller MD
Rev Mal Respir; 1999 Feb; 16(1):29-37. PubMed ID: 10091258
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury.
Nagata K; Iwasaki Y; Yamada T; Yuba T; Kono K; Hosogi S; Ohsugi S; Kuwahara H; Marunaka Y
Respir Med; 2007 Apr; 101(4):800-7. PubMed ID: 17010595
[TBL] [Abstract][Full Text] [Related]
50. Oxidant stress and adult respiratory distress syndrome.
Brigham KL
Eur Respir J Suppl; 1990 Oct; 11():482s-484s. PubMed ID: 2278607
[TBL] [Abstract][Full Text] [Related]
51. N-acetyl cysteine attenuates acute lung injury in the rat.
Davreux CJ; Soric I; Nathens AB; Watson RW; McGilvray ID; Suntres ZE; Shek PN; Rotstein OD
Shock; 1997 Dec; 8(6):432-8. PubMed ID: 9421857
[TBL] [Abstract][Full Text] [Related]
52. A critical role for thiol, but not ATP, depletion in 95% O2-mediated injury of preterm pneumocytes in vitro.
Christie NA; Slutsky AS; Freeman BA; Tanswell AK
Arch Biochem Biophys; 1994 Aug; 313(1):131-8. PubMed ID: 8053673
[TBL] [Abstract][Full Text] [Related]
53. Protective effects of N-acetylcysteine on the peroxidative changes of rat lungs exposed to inhalation of thinners.
Dillioglugil MO; Ilgazli A; Maral H; Sengul C; Ozdemir G; Ercin C
Respirology; 2005 Nov; 10(5):615-9. PubMed ID: 16268915
[TBL] [Abstract][Full Text] [Related]
54. Lung cell oxidant injury: decrease in oxidant mediated cytotoxicity by N-acetylcysteine.
Simon LM; Suttorp N
Eur J Respir Dis Suppl; 1985; 139():132-5. PubMed ID: 3862606
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
